Microsofts Anthropic Partnership May Unlock 43 Billion Azure Revenue by 2030 HSBC Suggests US Iran Signal Progress on Middle East Peace But Remain Divided Over Uranium Enrichment and Strait of Hormuz Tolls Oppenheimer Maintains Outperform Rating on Gain Therapeutics Signaling Continued Confidence The Cigna Group CI Downgraded to Hold at Deutsche Bank Amid MultiYear Uncertainty EU Mandate on Attached Bottle Caps Highlights Regulatory Divergence Between Europe and US SpaceX Successfully Tests Redesigned Starship Ahead of Potential Landmark IPO Concentrix CNXC Q1 2026 Earnings EPS Miss and Revenue NonDisclosure Weigh on Sentiment KB Financial Group Q4 2025 Earnings Earnings Beat Estimates Amid Steady Performance NPO Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher AMTM Q1 2026 Earnings EPS Surpasses Estimates as Operating Improvements Take Hold Braskem Q1 2026 Earnings Massive EPS Surprise as Company Posts 181 Profit vs Expected Loss GNLN Q2 2023 Earnings Deep EPS Miss Triggers Selloff Janus International Group Inc JBI Notches Slight Gain as Stock Clings to Support Level Neuronetics STIM Holds at 122 as Stock Consolidates Near Key Support Nuveen Churchill Direct Lending Corp NCDL Edges Higher Remains in Consolidation Range Miluna Acquisition Corp Units MMTXU Holds Steady at 1010 Amid SPAC Market Calm Eupraxia Pharmaceuticals EPRX Rises 23 as Stock Approaches Key Resistance Level SpaceX Successfully Launches Starship Test Flight After Initial Scrub NewtekOne Inc NEWT Q1 2026 Earnings Earnings Miss but Stock Climbs on Optimism Recursion Pharmaceuticals RXRX Slips 13 as Biotech Stock Tests Key Support Near 282 Teads Holding Co TEAD Slides to 11 as Bearish Momentum Intensifies KT Corporation KT Faces Downward Pressure as Shares Decline 137 Gabelli Convertible and Income Securities Fund GCV Gains 154 as Support Holds Steady Ryvyl Inc RVYL Consolidates Near Key Support as Volume Signals Caution Oragenics Inc OGEN Edges Higher as Biotech Volatility Persists Charlton Aria Acquisition Rights CHARR Plunge on Heavy Selling Rights May Approach Expiration Innoviz Technologies INVZ Slides Toward Support Amid Continued Selling Pressure